In accordance with studies of AD-affected brains, pre-clinical studies on Nrf2-knockout transgenic mice with amyloidopathy and tauopathy reported that an Nrf2 deficit was associated with increased markers of oxidative stress and neuroinflammation, compared to the control mice. This evidence concerns the gene NFE2L2 and Alzheimer disease.